Leo Pharma, one of the leaders in medical dermatology, has appointed Kasper Künzel as Interim Vice President and General Manager for its UK and Ireland business.
Kasper is an established leader within Leo Pharma, having previously been Vice President, IPO Preparedness Office, at Leo Pharma in Denmark.
Kasper brings over 17 years of pharmaceutical experience, previously taking on local and global leadership positions across Leo Pharma in functions including R&D, Finance and Commercial. Having first joined Leo Pharma in Denmark in a financial function, his previous roles include General Manager in South Korea, Vice President of Corporate Transformation, and Director of R&D Business Finance
He commented: “I am delighted to join the Leo Pharma UK and Ireland team and continue to build on the company’s strong heritage in these markets. The UK and Ireland team are committed to the Leo Pharma values as a leader in medical dermatology, and I’m looking forward to all we can achieve together this year.
My priorities in this new role will be to understand the key challenges and opportunities in the UK and Ireland – not only for Leo Pharma as a business, but also what our partners and patients are facing – to ensure informed and strategic decisions deliver positive outcomes for the dermatology community and the business. I firmly believe in being externally focussed, whilst also building high performance teams and nurturing talent development. We have the potential and ambition to be the preferred dermatology care partner, improving people’s lives around the world, and I believe we have an exciting future ahead.”
Kasper is already in this interim role as of January 2023 and will remain in place until a permanent Vice President and General Manager for Leo Pharma UK and Ireland joins this business.